60 Biggest Movers From Yesterday

Gainers

• Aimmune Therapeutics, Inc AIMT shares jumped 171.6% to close at $34.22 on Monday after Nestle SA agreed to acquire the company at an enterprise value of $2.6 billion.
• Applied UV, Inc. AUVI shares gained 132% to close at $11.60 after the company prices its IPO at $5 per share.
• Akcea Therapeutics, Inc. AKCA rose 60.6% to close at $18.28 after the company announced it will be acquired by Ionis Pharmaceuticals for $18.15 per share in cash.
• Hermitage Offshore Services Ltd. PSV gained 50.6% to close at $1.16. Hermitage Offshore Services, on Friday, announced it submitted a request to appeal the NYSE delisting determination.
• Genworth Financial, Inc. GNW shares gained 27.4% to close at $3.02 following a media report that a potential buyer has financing.
• I-Mab IMAB rose 27.2% to close at $39.44 after reporting a loss for the first half of the year.
• GameStop Corp. GME surged 23.9% to close at $6.68 after RC Ventures reported a 9% active stake in the company on Friday.
• AgEagle Aerial Systems, Inc. UAVS gained 23% to close at $3.10.
• Color Star Technology Co., Ltd. HHT rose 22.9% to close at $1.34. Color Star Technology shares jumped 23% on Friday after the company announced collaboration with Red Phoenix Entertainment to strategically expand into sports education.
• AutoWeb, Inc. AUTO shares climbed 20.4% to close at $5.37 after dropping 8% on Friday.
• Kindred Biosciences, Inc. KIN gained 18.4% to close at $4.96. Kindred Biosciences swung to a Q2 profit last month.
• Sphere 3D Corp. ANY climbed 17% to close at $2.69 after jumping 30% on Friday. Sphere 3D, last month, entered into an agreement for acquisition of a commercial water-as-a-service supplier.
• Atomera Incorporated ATOM climbed 16.4% to close at $12.71. Atomera, during the month, posted a Q2 loss.
• AlloVir, Inc. ALVR shares rose 15.6% to close at $32.39.
• ProQR Therapeutics N.V. PRQR surged 15.6% to close at $6.30. ProQR released quarterly results last month.
• Pro-Dex, Inc. PDEX gained 15.4% to close at $28.86. Pro-Dex shares climbed around 18% on Friday after reporting a rise in quarterly earnings.
• Greenlane Holdings, Inc. GNLN surged 15.4% to close at $3.07.
• Northern Dynasty Minerals Ltd. NAK rose 15.3% to close at $1.05 on Monday after declining around 3% on Friday.
• Apellis Pharmaceuticals, Inc. APLS gained 14.7% to close at $30.83.
• Capricor Therapeutics, Inc. CAPR shares jumped 14.6% to close at $6.03. Capricor Therapeutics, last week, announced the U.S. Food and Drug Administration has accepted its investigational new drug application for a Phase 2clinical trial of CAP-1002 in patients with COVID-19.
• Edesa Biotech, Inc. EDSA shares surged 14.5% to close at $9.33. Edesa Biotech released quarterly results last month.
• Kirkland's, Inc. KIRK rose 14.1% to close at $8.67.
• Tesla, Inc. TSLA gained 12.6% to close at $498.32 as the stock begins trading on a split-adjusted basis, with the lower share price potentially attracting interest from retail investors.
• Utz Brands Inc. UTZ rose 12.6% to close at $18.40.
• Workhorse Group Inc. WKHS gained 10.5% to close at $18.11 after the company announced agreements with Hitachi to support higher production.
• VivoPower International PLC VVPR gained 10.5% to close at $9.12 after jumping 69% on Friday. The company reported better-than-expected FY20 preliminary results last week.
• UTStarcom Holdings Corp. UTSI gained 8.7% to close at $1.50. UTStarcom reported the launch of a SkyFlux Converged Packet Transport Platform and postponed the release of H1 financial results.
• eXp World Holdings, Inc. EXPI gained 8.6% to close at $44.48.
• Turquoise Hill Resources Ltd. TRQ rose 8% to close at $1.08. Turquoise Hill raised its 2021 gold production forecast and filed an updated Oyu Tolgoi Technical Report.
• ViewRay, Inc. VRAY shares gained 7.1% to close at $2.72.
• Amarin Corporation plc AMRN rose 5.4% to close at $7.76 after the company announced the results from the VASCEPA trial met the primary endpoint.
• FlexShopper, Inc. FPAY rose 5.2% to close at $2.23.
• BioCryst Pharmaceuticals, Inc. BCRX gained 4.5% to close at $4.15 after the company announced the FDA has granted Orphan Drug designation for its oral Factor D inhibitor, BCX9930, for the treatment of paroxysmal nocturnal hemoglobinuria.
• Gevo, Inc. GEVO shares rose 4.2% to close at $1.25. Gevo shares climbed 10% on Friday after Peak Value IP completed its valuation of the intellectual property of the company and valued it at $412 million.
• Apple Inc. AAPL gained 3.4% to close at $129.04 as the stock begins trading on a split-adjusted basis, with the lower share price potentially attracting interest from retail investors.

Check out these big penny stock gainers and losers

Losers

• Acasti Pharma Inc. ACST shares fell 65.5% to close at $0.2447 after the company announced the results from its Phase 3 TRILOGY 2 study of CaPre did not achieve statistical significance for the primary endpoint.
• Shiloh Industries, Inc. SHLO shares dropped 64.2% to close at $0.3901 on Monday after the company entered into stock and asset purchase agreement with Grouper Holdings, LLC, a Subsidiary of MiddleGround Capital LLC. The company filed voluntary Chapter 11 petitions to facilitate the transaction.
• Regis Corporation RGS fell 18.6% to close at $7.39 after reporting a loss for the fourth quarter.
• ADiTx Therapeutics, Inc. ADTX shares dropped 17.3% to close at $3.21. Aditxt, last week, submitted emergency use authorization application for AditxtScore test for COVID-19.
• Garrett Motion Inc. GTX dipped 16.7% to close at $2.75. Garrett Motion, last week, said it is exploring alternatives for balance sheet restructuring.
• Credit Acceptance Corporation CACC fell 15.8% to close at $386.80.
• SCWorx Corp. WORX shares declined 15% to close at $1.76 after declining 6% on Friday.
• PEDEVCO Corp. PED shares fell 13.2% to close at $1.32. PEDEVCO shares tumbled 28% on Friday after the company issued a second status update regarding open letter delivered to Avalon Energy, LLC.
• Moxian, Inc. MOXC dipped 12.2% to close at $2.24. Moxian, on August 25, regained compliance with Nasdaq listing rule.
• The Chefs' Warehouse, Inc. CHEF shares fell 11.6% to close at $14.81.
• Venus Concept Inc. VERO dipped 11.6% to close at $2.87. Venus Concept, last month, reported a Q2 loss.
• Dada Nexus Limited DADA dropped 11.4% to close at $22.76. Dada Nexus, last week, reported upbeat quarterly results.
• Calix, Inc. CALX shares declined 11.3% to close at $19.45.
• Lipocine Inc. LPCN shares fell 10.3% to close at $1.48 after the FDA informed the company that it needs additional time to complete its review of TLANDO's New Drug Application.
• BigCommerce Holdings, Inc. BIGC fell 10.1% to close at $117.80 after several analysts initiated coverage on the company's stock with neutral to bearish ratings.
• Overstock.com, Inc. OSTK shares fell 9.7% to close at $87.50.
• Odonate Therapeutics, Inc. ODT fell 9.7% to close at $16.15 after gaining 21% on Friday. Odonate Therapeutics, last week, announced a common stock offering.
• Urban One, Inc. UONE shares fell 9.6% to close at $3.68. Urban One, earlier during the month, announced $25 million at-the-market equity offering program.
• Orchard Therapeutics plc ORTX shares fell 8.1% to close at $5.93.
• Hancock Jaffe Laboratories, Inc. HJLI fell 7.8% to close at $0.41. Hancock Jaffe Laboratories, last week, enrolled the first two patients for its first-in-human CoreoGraft study.
• Town Sports International Holdings, Inc. CLUB shares fell 7.7% to close at $0.5901 after gaining over 8% on Friday.
• India Globalization Capital, Inc. IGC fell 7.7% to close at $1.20. India Globalization Capital reported a Q2 loss last month.
• RumbleON, Inc. RMBL shares fell 7.5% to close at $37.20.
• Tyme Technologies, Inc. TYME shares fell 7.3% to close at $1.01 after declining over 4% on Friday. TYME, last week, reported that its oncology research revealed a potential new oral therapy TYPE-19 in 'fight against COVID-19.'
• Destination XL Group, Inc. DXLG fell 6.3% to close at $0.3325 after declining 21% on Friday. Destination XL Group, last week, reported better-than-expected Q2 sales.